[Results of clinical studies of benzodet and ethoxybenzodet preparations].
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008207:Lymphatic Metastasis / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy; D014227:Triazines / Q000009:adverse effects* / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D014227:Triazines
Rezul'taty klinicheskogo izucheniia preparatov benozdéta i étoksibensodéta.